Genetically engineered "Chlamydomonas reinhardtii" has been used to produce a mammalian serum amyloid protein, a human antibody protein, human Vascular endothelial growth factor, a potential therapeutic Human Papillomavirus 16 vaccine, a potential malaria vaccine (an edible algae vaccine), and a complex designer drug that could be used to treat cancer.